Report - CAS CLINIQUES Complications respiratoires de l’immunothérapie · essai de phase 1 avec le pembrolizumab 10mg/kg tous les 21 jours J1C1 November 18 2013 irAE apparu December 31st

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form